InsmedINSM
那斯達克 · USD
91.88
-7.16
(-7.23%)
收盤 06/11 03:59 (UTC+8)
盤後
91.50
91.50
(-0.41%)
06/11 03:59 (UTC+8)
InsmedINSM
91.88
-7.16
(-7.23%)
財務數據
損益表
- 0.84
- 0.76
- 0.90
- 0.93
- 1.04
- 0.93
- 1.07
- 1.42
- 2.64
- 3.06
- 5.84
- -9.79
- 19.66
- 3.41
- 11.79
- -11.12
- 15.72
- 32.52
- 85.36
- 15.96
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 305,964 | 263,843 | 142,342 | 107,415 | 92,823 | 104,442 | 93,425 | 90,340 | 75,500 | 83,693 |
營業成本 | 47,420 | 44,220 | 29,365 | 28,075 | 21,278 | 26,151 | 21,170 | 20,964 | 17,457 | 18,443 |
營業毛利 | 258,544 | 219,623 | 112,977 | 79,340 | 71,545 | 78,291 | 72,255 | 69,376 | 58,043 | 65,250 |
營業費用 | 411,864 | 539,371 | 478,982 | 392,216 | 319,685 | 308,705 | 285,684 | - | 203,548 | 243,522 |
研發費用 | 209,485 | 254,911 | 186,415 | 177,190 | 152,577 | 179,727 | 150,809 | 146,748 | 121,083 | 137,029 |
推銷及管理費用 | 200,298 | 282,523 | 291,029 | 213,763 | 165,845 | 127,715 | 133,612 | 210,269 | 81,202 | 105,230 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 2,081 | 1,937 | 1,538 | 1,263 | 1,263 | 1,263 | 1,263 | 1,263 | 1,263 | 1,263 |
營業利益 | -200,281 | -319,748 | -366,005 | -312,876 | -248,140 | -230,414 | -213,429 | -288,904 | -145,505 | -178,272 |
其他收入及費用 | 11,304 | 13,413 | 17,686 | 13,678 | 14,038 | 16,812 | 18,825 | 10,016 | 7,683 | 12,023 |
利息費用 | 20,082 | 20,599 | 20,382 | 21,245 | 21,569 | 21,550 | 21,054 | 21,267 | 21,042 | 20,784 |
稅前純益 | -162,098 | -326,934 | -368,701 | -320,443 | -255,671 | -234,282 | -219,510 | -299,771 | -156,502 | -185,063 |
所得稅 | 1,465 | 1,551 | 1,320 | 1,243 | 912 | 1,266 | 1,014 | 838 | 589 | 998 |
稅後純益 | -163,563 | -328,485 | -370,021 | -321,686 | -256,583 | -235,548 | -220,524 | -300,609 | -157,091 | -186,061 |
基本每股稅後盈餘(元) | -0.76 | -1.54 | -1.75 | -1.70 | -1.42 | -1.32 | -1.27 | -1.94 | -1.06 | -1.28 |
稀釋每股稅後盈餘(元) | -0.76 | -1.53 | -1.77 | -1.70 | -1.42 | -1.30 | -1.25 | -1.96 | -1.06 | -1.28 |
基本平均股數(千股) | 215468.00 | 213637.00 | 211759.00 | 189302.00 | 180860.00 | 179021.00 | 173721.00 | 154702.00 | 148456.00 | 144806.00 |
稀釋平均股數(千股) | 215468.00 | 213637.00 | 211759.00 | 189302.00 | 180860.00 | 179021.00 | 173721.00 | 154702.00 | 148456.00 | 144806.00 |
還原基本每股稅後盈餘(元) | -0.76 | -1.54 | -1.75 | -1.70 | -1.42 | -1.32 | -1.27 | -1.94 | -1.06 | -1.28 |
還原稀釋每股稅後盈餘(元) | -0.76 | -1.53 | -1.77 | -1.70 | -1.42 | -1.30 | -1.25 | -1.96 | -1.06 | -1.28 |
還原基本平均股數(千股) | 215,468 | 213,637 | 211,759 | 189,302 | 180,860 | 179,021 | 173,721 | 154,702 | 148,456 | 144,806 |
還原稀釋平均股數(千股) | 215,468 | 213,637 | 211,759 | 189,302 | 180,860 | 179,021 | 173,721 | 154,702 | 148,456 | 144,806 |
EBITDA(千元) | -141,454 | -309,117 | -354,344 | -300,675 | -236,788 | -218,592 | -199,741 | -273,327 | -132,043 | -162,203 |